Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients
Clinical trial NCT04839341 · COMPLETED
Trial details
- NCT number
- NCT04839341
- Sponsor
- Apollomics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2024-06-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.